KristenMariePettitMD

PubMed

• Exploring Adolescent and Young Adult Cancer Survivors' Experience with Cancer Treatment-Related Symptoms: A Qualitative Analysis of Semi-Structured Interviews.
  Robert Knoerl, Katherine Grandinetti, Liat Smener, Emily Doll, N Lynn Henry, Emily Walling, Anao Zhang, Debra Barton, Leslie A Fecher, Yasmin Karimi, Kristen Pettit, S...> ;Journal of Adolescent and Young Adult Oncology. 2024 Apr 18
• Quantitative MRI reveals heterogeneous impacts of treatment on diseased bone marrow in a mouse model of myelofibrosis.
  Tanner H Robison, Winston Lee, Kathryn E Luker, Kristen Pettit, Moshe Talpaz, Thomas L Chenevert, Brian D Ross, Gary D Luker> ;Magnetic Resonance in Medicine. 2024 Jun 1
• Tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax and hypomethylating agents with or without dose ramp-up.
  Christy J Khouderchah, Lydia L Benitez, Bernard L Marini, Martina Fraga, Kristen Pettit, Patrick W Burke, Dale L Bixby, Anthony J Perissinotti> ;Leukemia & Lymphoma. 2024 Feb 1
• 2 citations
  Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling.
  Samuel B Reynolds, Kristen Pettit, Malathi Kandarpa, Moshe Talpaz, Qing Li> ;Cancers. 2023 Sep 21
• 1 citations
  A Phase Ib Trial of AVID200, a TGFβ 1/3 Trap, in Patients with Myelofibrosis.
  John Mascarenhas, Anna Rita Migliaccio, Heidi Kosiorek, Rupali Bhave, Jeanne Palmer, Andrew Kuykendall, Ruben Mesa, Raajit K Rampal, Aaron T Gerds, Abdulraheem Yacoub,...> ;Clinical Cancer Research. 2023 Sep 15
• 6 citations
  New approaches to tackle cytopenic myelofibrosis.
  Samuel B Reynolds, Kristen Pettit> ;Hematology. American Society of Hematology. Education Program. 2022 Dec 9
• 5 citations
  Multiparametric MRI to quantify disease and treatment response in mice with myeloproliferative neoplasms.
  Tanner H Robison, Manisha Solipuram, Kevin Heist, Ghoncheh Amouzandeh, Winston Y Lee, Brock A Humphries, Johanna M Buschhaus, Avinash Bevoor, Anne Zhang, Kathryn E Luk...> ;JCI Insight. 2022 Oct 10
• Solving coagulation conundrums: comparing prophylaxis strategies in adult patients receiving PEG-asparaginase.
  YeeAnn Chen, Kaitlyn Buhlinger, Anthony J Perissinotti, Allison J Schepers, Lydia Benitez, Jessica Auten, Sheh-Li Chen, Dale L Bixby, Patrick W Burke, Kristen M Pettit...> ;Leukemia & Lymphoma. 2022 Nov 1
• 3 citations
  Oncology stewardship in acute myeloid leukemia.
  Madeleine A Ochs, Bernard L Marini, Anthony J Perissinotti, Charles E Foucar, Kristen Pettit, Patrick Burke, Dale L Bixby, Lydia L Benitez> ;Annals of Hematology. 2022 Aug 1
• 6 citations
  Management of Myeloproliferative Neoplasms in the Molecular Era: From Research to Practice.
  Kristen Pettit, Alexandra Rezazadeh, Ehab L Atallah, Jerald Radich> ;American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2022 Apr 1
• 1 citations
  Multicenter comparison of first salvage chemotherapy versus novel therapy regimens in adult relapsed/refractory acute lymphoblastic leukemia.
  Madeleine A Ochs, Bernard L Marini, Lydia L Benitez, Sarah E Stump, Taylor M Weis, Kaitlyn M Buhlinger, Thomas Diaz, Justin H Reid, Benyam Muluneh, Kristen Pettit, Pat...> ;Leukemia & Lymphoma. 2022 Aug 1
• Impact of number of lumens in central-venous catheters on central-line bloodstream infection (CLABSI) and venous thromboembolism (VTE) risk in patients with acute leuk...
  Alina Varabyeva, Christabel Pui-See Lo, Adamo Brancaccio, Anthony J. Perissinotti, Twisha S Patel, Katie Sandison, Lydia L. Benitez, Kristen Pettit, Patrick W. Burke, ...> ;Infection Control and Hospital Epidemiology. 2021 Oct 18
• 7 citations
  Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase Inhibitors.
  Justin Shaya, Kristen Pettit, Malathi Kandarpa, Dale L. Bixby, Jessica Mercer, Moshe Talpaz> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Jul 18
• 3 citations
  Improving symptom burden and quality of life in patients with myelofibrosis: current strategies and future directions.
  James J. Yoon, Kristen Pettit> ;Expert Review of Hematology. 2021 Aug 9
• 1 citations
  Real world use of FLT3 inhibitors for treatment of FLT3+ acute myeloid leukemia (AML): A single center, propensity-score matched, retrospective cohort study.
  Brian Bazzell, Bernard L. Marini, Lydia L. Benitez, Dale L. Bixby, Patrick W. Burke, Kristen Pettit, Anthony J. Perissinotti> ;Journal of Oncology Pharmacy Practice. 2021 Jun 1
• 8 citations
  Multicenter comparison of high-dose cytarabine-based regimens versus liposomal daunorubicin and cytarabine (CPX-351) in patients with secondary acute myeloid leukemia.
  Lydia L. Benitez, Anthony J. Perissinotti, Caitlin R. Rausch, Jeff Klaus, Stephen M Clark, Michael Filtz, Kelley L Ratermann, Carissa Treptow, Shawn Griffin, Marissa O...> ;Leukemia & Lymphoma. 2021 Apr 8
• 4 citations
  Utility of methicillin-resistant staphylococcus aureus (MRSA) nasal screening in patients with acute myeloid leukemia (AML).
  Millicynth Talagtag, Twisha S Patel, Gianni B. Scappaticci, Anthony J. Perissinotti, Allison J Schepers, Lindsay A Petty, Kristen Pettit, Patrick W. Burke, Dale L. Bix...> ;Transplant Infectious Disease. 2021 Apr 7
• 5 citations
  Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts.
  Justin H Reid, Anthony J. Perissinotti, Lydia L. Benitez, Daniel F. Boyer, Winston Y Lee, Patrick W. Burke, Kristen Pettit, Dale L. Bixby, Bernard L. Marini> ;Leukemia Research. 2021 Feb 19
• 4 citations
  Impact of high dose cytarabine dosing strategies in obese patients with acute myeloid leukemia.
  Madeleine A. Ochs, Anthony J. Perissinotti, Bernard L. Marini, Patrick W. Burke, Dale L. Bixby, Kristen Pettit, Lydia L. Benitez> ;Leukemia Research. 2021 Mar 1
• 1 citations
  Propensity-score Matched Comparison of Salvage Chemotherapy Regimens in Relapsed/Refractory Acute Myeloid Leukemia.
  Justin H Reid, Bernard L. Marini, Lydia L. Benitez, Kristen Pettit, Dale L. Bixby, Patrick W. Burke, Anthony J. Perissinotti> ;Clinical Lymphoma, Myeloma & Leukemia. 2021 Jan 19
• 170 citations
  Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia
  Geoffrey L. Uy, Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani, John E. Godwin, Martha Arellano, Kendra Sweet, Ashkan Emadi,...> ;Blood. 2021 Feb 11
• 5 citations
  Non-Pharmacologic Management of Splenomegaly for Patients with Myelofibrosis: Is There Any Role for Splenectomy or Splenic Radiation in 2020?
  Kamya Sankar, Kristen Pettit> ;Current Hematologic Malignancy Reports. 2020 Oct 1
• 3 citations
  Impact of prophylactic intrathecal chemotherapy on CNS relapse rates in AML patients presenting with hyperleukocytosis.
  Justin H Reid, Anthony J. Perissinotti, Lydia L. Benitez, Dale L. Bixby, Patrick W. Burke, Kristen Pettit, Bernard L. Marini> ;Leukemia & Lymphoma. 2020 Mar 20
• 2 citations
  Successful use of blinatumomab in a patient with acute lymphoblastic leukemia and severe hepatic dysfunction
  Adam C Robinson, Bernard L. Marini, Kristen Pettit, Anthony J. Perissinotti> ;Journal of Oncology Pharmacy Practice. 2020 Jan 1
• 6 citations
  Intrathecal alemtuzumab: a potential treatment of refractory leptomeningeal T-cell prolymphocytic leukemia
  Fares Alsawah, Lydia L. Benitez, Sarah Choi, Bernard L. Marini, Anthony J. Perissinotti, Amy Skyles, Patrick W. Burke, Kristen Pettit, Ashley Crouch, Heather Fox, Dale...> ;Blood Advances. 2019 Nov 12
• Join now to see all

Abstracts/Posters

• Phase 1b Study of the Epichaperome Inhibitor PU-H71 Administered Orally with Ruxolitinib Continuation for the Treatment of Patients with Myelofibrosis
  Kristen Pettit, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Integrated Genomic-Transcriptomic Study Highlights Accumulation of Genetic Variants and Activation of Inflammatory Pathways
  Kristen Pettit, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Multi-Center Retrospective Evaluation of High-Dose Cytarabine Based Induction Versus CPX-351 Induction in Patients with Secondary AML
  Kristen Pettit, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019